ALEC
Alector Inc
NASDAQ: ALEC · HEALTHCARE · BIOTECHNOLOGY
$2.37
+3.04% today
Updated 2026-04-30
Market cap
$255.36M
P/E ratio
—
P/S ratio
12.13x
EPS (TTM)
$-1.39
Dividend yield
—
52W range
$1 – $3
Volume
0.7M
Alector Inc (ALEC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-588.00%
ROE
-181.60%
ROA
-25.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $416000.00 | $-15.11M | -3,187.02% | -3,637.50% | -3,632.21% |
| 2017 | $3.73M | $-32.48M | -700.83% | -874.94% | -869.61% |
| 2018 | $27.68M | $-52.25M | 100.00% | -206.99% | -188.78% |
| 2019 | $21.22M | $-99.81M | 100.00% | -539.16% | -470.39% |
| 2020 | $21.10M | $-182.96M | 100.00% | -925.08% | -867.21% |
| 2021 | $207.09M | $-28.01M | 100.00% | -18.04% | -13.53% |
| 2022 | $133.62M | $-133.31M | 100.00% | -103.16% | -99.77% |
| 2023 | $97.06M | $-130.39M | 90.88% | -156.33% | -134.34% |
| 2024 | $100.56M | $-119.05M | 100.00% | -144.19% | -118.39% |
| 2025 | $21.05M | $-142.93M | 54.09% | -692.83% | -679.16% |